Internal Medicine and Nephrology, Kidney Stone Center Zurich, Klinik Im Park and University of Zurich, Bellariastrasse 38, CH-8038, Zurich, Switzerland.
Department of Cardiac Surgery, University Hospital, Zurich, Switzerland.
J Nephrol. 2022 Jul;35(6):1619-1626. doi: 10.1007/s40620-021-01207-7. Epub 2022 Jan 1.
Prospective evaluation of the prevalence of incomplete distal renal tubular acidosis (idRTA) in idiopathic calcium stone formers (ICSF) diagnosed by half-dose ammonium chloride loading (NHCl, 0.05 g/kg body weight/day) and impact of alkali treatment of idRTA.
Evaluation of 386 consecutive idiopathic calcium stone formers (ICSF) (280 males, 106 females) for idRTA. If screening fasting urine pH was > 5.80, 1-day NHCl loading was performed without severe adverse effects. Normally, urine pH falls below 5.45.
Sixty-four idiopathic calcium stone formers exhibited idRTA, one complete dRTA. Prevalence was higher in women (25.4%) than in men (13.6%). Thus, for more equilibrated comparisons, we formed pairs of 62 idiopathic calcium stone formers (ICSF) with and 62 without idRTA, matched for gender, age, BMI and serum creatinine. Idiopathic calcium stone formers with idRTA more often had hypercalciuria (p < 0.025) and urine citrate < 2 mmol/d (p < 0.05), formed calcium phosphate stones more frequently, exhibited higher numbers of stones/year (1.4 ± 1.5 vs. 0.9 ± 0.8, p = 0.034) and 2.5 times more intrarenal calcifications (4.6 ± 5.9 vs. 1.8 ± 3.6, p = 0.002). All idiopathic calcium stone formers with idRTA were recommended chronic alkali therapy. After 4-15 years of follow-up, stone events /years follow-up (stone passage or urologic intervention) were higher in patients non-adherent to alkali therapy (0.61 ± 0.92) than in patients adherent to treatment (0.11 ± 0.21, p = 0.006).
Incomplete distal renal tubular acidosis is 1.8-fold more prevalent among female idiopathic calcium stone formers, predicts more stone recurrences, predisposes to calcium phosphate stones and is associated with 2.5 times more intrarenal calcifications vs. non-idRTA patients. Chronic alkali treatment reduces clinical stone recurrences by 5.5 times.
前瞻性评估通过半剂量氯化铵负荷(NHCl,0.05g/kg 体重/天)诊断的特发性钙结石形成者(ICSF)中不完全远端肾小管酸中毒(idRTA)的患病率,以及碱治疗对 idRTA 的影响。
评估 386 例连续的特发性钙结石形成者(ICSF)(280 名男性,106 名女性)是否存在 idRTA。如果筛查空腹尿 pH 值>5.80,则在无严重不良反应的情况下进行 1 天 NHCl 负荷。通常情况下,尿液 pH 值会降至 5.45 以下。
64 名特发性钙结石形成者存在 idRTA,1 名存在完全性 dRTA。女性(25.4%)的患病率高于男性(13.6%)。因此,为了进行更均衡的比较,我们根据性别、年龄、BMI 和血清肌酐将 62 名特发性钙结石形成者与 62 名无 idRTA 的特发性钙结石形成者配对。存在 idRTA 的特发性钙结石形成者更常出现高钙尿症(p<0.025)和尿枸橼酸盐<2mmol/d(p<0.05),更常形成磷酸钙结石,每年结石数量更多(1.4±1.5 比 0.9±0.8,p=0.034),并且肾内钙化的发生率高 2.5 倍(4.6±5.9 比 1.8±3.6,p=0.002)。所有存在 idRTA 的特发性钙结石形成者均被推荐进行慢性碱治疗。经过 4-15 年的随访,未坚持碱治疗的患者结石事件/年随访(结石排出或泌尿科干预)更高(0.61±0.92),而坚持治疗的患者结石事件/年随访(0.11±0.21,p=0.006)。
女性特发性钙结石形成者中不完全远端肾小管酸中毒的患病率高 1.8 倍,预测结石复发更多,易发生磷酸钙结石,并且与非 idRTA 患者相比,肾内钙化的发生率高 2.5 倍。慢性碱治疗可使临床结石复发减少 5.5 倍。